Upregulation of estrogen receptor α and mediation of 17β-estradiol vasoprotective effects via estrogen receptor α in basilar arteries in rats after experimental subarachnoid hemorrhage: Laboratory investigation

Journal of Neurosurgery

Volumn 109, Issue 1, 2008, Pages 92-99

  Shih, Huei Chuan ^a,d   Lin, Chih Lung ^c   Wu, Shu Chuan ^c   Kwan, Aij Lie ^c   Hong, Yi Ren ^b   Howng, Shen Long ^a,c  

^a Department of Otorhinolaryngology Head and Neck Surgery   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d MEIHO UNIVERSITY   (Taiwan)

Author keywords

Cerebral vasospasm; Estrogen receptor; Subarachnoid hemorrhage

Indexed keywords

CHRYSENE DERIVATIVE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTRADIOL BENZOATE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; INDUCIBLE NITRIC OXIDE SYNTHASE; METHYLPIPERIDINOPYRAZOLE; PYRAZOLE DERIVATIVE; TETRAHYDROCHRYSENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASILAR ARTERY; BRAIN ARTERY; BRAIN VASOSPASM; CONTROLLED STUDY; DRUG MECHANISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBARACHNOID HEMORRHAGE; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BASILAR ARTERY; BENZOATES; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; MALE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SUBARACHNOID HEMORRHAGE;

EID: 46449123992     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/JNS/2008/109/7/0092     Document Type: Article

References (54)

1. Andersson C, Lydrup ML, Ferno M, Idvall I, Gustafsson J, Nilsson BO: Immunocytochemical demonstration of oestrogen receptor beta in blood vessels of the female rat. J Endocrinol 169:241-247, 2001
2. Beato M: Gene regulation by steroid hormones. Cell 56:335-344, 1989
3. Chakraborti S, Michael JR: Role of protein kinase C in oxidant-mediated activation of phospholipase A2 in rabbit pulmonary arterial smooth muscle cells. Mol Cell Biochem 122:9-15, 1993
4. Costa RH: FoxM1 dances with mitosis. Nat Cell Biol 7:108-110, 2005
5. Darblade B, Pendaries C, Krust A, Dupont S, Fouque MJ, Rami J, et al: Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor. Circ Res 90:413-419, 2002
6. Davis AM, Ellersieck MR, Grimm KM, Rosenfeld CS: The effects of the selective estrogen receptor modulators, methyl-piperidino-pyrazole (MPP), and raloxifene in normal and cancerous endometrial cell lines and in the murine uterus. Mol Reprod Dev 73:1034-1044, 2006
7. Farhat MY, Lavigne MC, Ramwell PW: The vascular protective effects of estrogen. FASEB J 10:615-624, 1996
8. Frasor J, Barkai U, Zhong L, Fazleabas AT, Gibori G: PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase. Mol Endocrinol 15:1941-1952, 2001
9. Frasor J, Gibori G: Prolactin regulation of estrogen receptor expression. Trends Endocrinol Metab 14:118-123, 2003
10. Frasor J, Park K, Byers M, Telleria C, Kitamura T, Yu-Lee LY, et al: Differential roles for signal transducers and activators of transcription 5a and 5b in PRL stimulation of ERalpha and ERbeta transcription. Mol Endocrinol 15:2172-2181, 2001
11. Gingerich S, Krukoff TL: Estrogen in the paraventricular nucleus attenuates L-glutamate-induced increases in mean arterial pressure through estrogen receptor beta and NO. Hypertension 48:1130-1136, 2006
12. Gisclard V, Miller VM, Vanhoutte PM: Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 244:19-22, 1988
13. Goffin V, Binart N, Touraine P, Kelly PA: Prolactin: the new biology of an old hormone. Annu Rev Physiol 64:47-67, 2002
14. Griendling KK, Sorescu D, Ushio-Fukai M: NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86:494-501, 2000
15. Hatake K, Wakabayashi I, Kakishita E, Hishida S: Impairment of endothelium-dependent relaxation in human basilar artery after subarachnoid hemorrhage. Stroke 23:1111-1117, 1992
16. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G: Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci U S A 89:11259-11263, 1992
17. Hino A, Tokuyama Y, Weir B, Takeda J, Yano H, Bell GI, et al: Changes in endothelial nitric oxide synthase mRNA during vasospasm after subarachnoid hemorrhage in monkeys. Neurosurgery 39:562-568, 1996
18. Hirose H, Ide K, Sasaki T, Takahashi R, Kobayashi M, Ikemoto F, et al: The role of endothelin and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dog. Eur J Pharmacol 277:77-87, 1995
19. Jesmin S, Hattori Y, Sakuma I, Liu MY, Mowa CN, Kitabatake A: Estrogen deprivation and replacement modulate cerebral capillary density with vascular expression of angiogenic molecules in middle-aged female rats. J Cereb Blood Flow Metab 23:181-189, 2003
20. Kaptain GJ, Lanzino G, Kassell NF: Subarachnoid haemorrhage: epidemiology, risk factors, and treatment options. Drugs Aging 17:183-199, 2000
21. Karas RH, Patterson BL, Mendelsohn ME: Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 89:1943-1950, 1994
22. Khurana VG, Smith LA, Baker TA, Eguchi D, O'Brien T, Katusic ZS: Protective vasomotor effects of in vivo recombinant endothelial nitric oxide synthase gene expression in a canine model of cerebral vasospasm. Stroke 33:782-789, 2002
23. Kim DE, Suh YS, Lee MS, Kim KY, Lee JH, Lee HS, et al: Vascular NAD(P)H oxidase triggers delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 33:2687-2691, 2002
24. Kim P, Schini VB, Sundt TM Jr, Vanhoutte PM: Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Circ Res 70:248-256, 1992
25. Kuiper GG, Gustafsson JA: The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Lett 410:87-90, 1997
26. Laoukili J, Kooistra MR, Bras A, Kauw J, Kerkhoven RM, Morrison A, et al: FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol 7:126-136, 2005
27. Li PF, Dietz R, von Harsdorf R: Reactive oxygen species induce apoptosis of vascular smooth muscle cell. FEBS Lett 404:249-252, 1997
28. Lin CL, Shih HC, Dumont AS, Kassell NF, Lieu AS, Su YF, et al: The effect of 17beta-estradiol in attenuating experimental subarachnoid hemorrhage-induced cerebral vasospasm. J Neurosurg 104:298-304, 2006
29. Lindner V, Kim SK, Karas RH, Kuiper GG, Gustafsson JA, Mendelsohn ME: Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury. Circ Res 83:224-229, 1998
30. Ma RY, Tong TH, Cheung AM, Tsang AC, Leung WY, Yao KM: Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c. J Cell Sci 118:795-806, 2005
31. MacRitchie AN, Jun SS, Chen Z, German Z, Yuhanna IS, Sherman TS, et al: Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. Circ Res 81:355-362, 1997
32. Madureira PA, Varshochi R, Constantinidou D, Francis RE, Coombes RC, Yao KM, et al: The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells. J Biol Chem 281:25167-25176, 2006
33. McNeill AM, Zhang C, Stanczyk FZ, Duckles SP, Krause DN: Estrogen increases endothelial nitric oxide synthase via estrogen receptors in rat cerebral blood vessels: effect preserved after concurrent treatment with medroxyprogesterone acetate or progesterone. Stroke 33:1685-1691, 2002
34. Mendelsohn ME, Karas RH: Estrogen and the blood vessel wall. Curr Opin Cardiol 9:619-626, 1994
35. Mori T, Nagata K, Town T, Tan J, Matsui T, Asano T: Intracisternal increase of superoxide anion production in a canine subarachnoid hemorrhage model. Stroke 32:636-642, 2001
36. Orimo A, Inoue S, Ouchi Y, Orimo H: Vascular smooth muscle cells possess estrogen receptor and respond to estrogen. Ann N Y Acad Sci 748:592-594, 1995
37. Rao GN, Berk BC: Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 70:593-599, 1992
38. Schievink WI: Intracranial aneurysms. N Engl J Med 336:28-40, 1997
39. Sen CK, Packer L: Antioxidant and redox regulation of gene transcription. FASEB J 10:709-720, 1996
40. Shih HC, Lin CL, Lee TY, Lee WS, Hsu C: 17beta-Estradiol inhibits subarachnoid hemorrhage-induced inducible nitric oxide synthase gene expression by interfering with the nuclear factor kappa B transactivation. Stroke 37:3025-3031, 2006
41. Shishido T, Suzuki R, Qian L, Hirakawa K: The role of superoxide anions in the pathogenesis of cerebral vasospasm. Stroke 25: 864-868, 1994
42. Sobey CG, Faraci FM: Subarachnoid haemorrhage: what happens to the cerebral arteries? Clin Exp Pharmacol Physiol 25:867-876, 1998
43. Sudoh N, Toba K, Akishita M, Ako J, Hashimoto M, Iijima K, et al: Estrogen prevents oxidative stress-induced endothelial cell apoptosis in rats. Circulation 103:724-729, 2001
44. Suzuki H, Kanamaru K, Tsunoda H, Inada H, Kuroki M, Sun H, et al: Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats. J Clin Invest 104:59-66, 1999
45. Tamir S, Izrael S, Vaya J: The effect of oxidative stress on ERalpha and ERbeta expression. J Steroid Biochem Mol Biol 81:327-332, 2002
46. Venkov CD, Rankin AB, Vaughan DE: Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation 94:727-733, 1996
47. Vikman P, Beg S, Khurana TS, Hansen-Schwartz J, Edvinsson L: Gene expression and molecular changes in cerebral arteries following subarachnoid hemorrhage in the rat. J Neurosurg 105:438-444, 2006
48. Wang IC, Chen YJ, Hughes D, Petrovic V, Major ML, Park HJ, et al: Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol 25:10875-10894, 2005
49. Watanabe Y, Chu Y, Andresen JJ, Nakane H, Faraci FM, Heistad DD: Gene transfer of extracellular superoxide dismutase reduces cerebral vasospasm after subarachnoid hemorrhage. Stroke 34:434-440, 2003
50. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S: Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A 91:5212-5216, 1994
51. Widenka DC, Medele RJ, Stummer W, Bise K, Steiger HJ: Inducible nitric oxide synthase: a possible key factor in the pathogenesis of chronic vasospasm after experimental subarachnoid hemorrhage. J Neurosurg 90:1098-1104, 1999
52. Williams JK, Adams MR, Klopfenstein HS: Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 81:1680-1687, 1990
53. Zafari AM, Ushio-Fukai M, Akers M, Yin Q, Shah A, Harrison DG, et al: Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension 32:488-495, 1998
54. Zalba G, Beaumont FJ, San Jose G, Fortuno A, Fortuno MA, Etayo JC, et al: Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 35:1055-1061, 2000